Identity theft is the fraud de jour, but old-fashioned con artists are still alive and well. A new study looks at who's most susceptible — and it's not always who you might think. Apryl Lundsten reports.

Merck's arthritis drug Vioxx is back in court today as an 11th case goes to trial, but the legal landscape of the ongoing litigation has changed considerably. Helen Palmer reports.

Federal investigators got their first guilty plea in the stock options backdating scandal. The outcome could give executives at the other 140 companies involved even more to worry about. Bob Moon reports.

Former Enron CEO Jeffry Skilling faces at least 20 years in prison for his role in the company's collapse when he is sentenced today for fraud and conspiracy. Jeff Tyler reports.